Allarity Therapeutics, Inc. (ALLR) Operating cash flow 2020–2025
Allarity Therapeutics, Inc. (ALLR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$14.8MFY2025 · since FY2020: -$7.3M → -$14.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.8M | +14.6% |
| FY2024 | -$17.4M | -36.1% |
| FY2023 | -$12.7M | +24.2% |
| FY2022 | -$16.8M | -13.0% |
| FY2021 | -$14.9M | -105.3% |
| FY2020 | -$7.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALLR financial trends
ALLR RevenueALLR Net incomeALLR Net marginALLR Gross profitALLR Gross marginALLR Operating incomeALLR Operating marginALLR Free cash flowALLR Capital expendituresALLR Return on equityALLR Stock buybacksALLR Dividends paidALLR Total assetsALLR Total liabilitiesALLR Shareholders’ equityALLR overview →